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A B S T R A C T
Background
The treatment of people with clinically significant postoperative pancreatic leaks is different from those without clinically significant
pancreatic leaks. It is important to know the diagnostic accuracy of drain fluid amylase as a triage test for the detection of clinically
significant pancreatic leaks, so that an informed decision can be made as to whether the patient with a suspected pancreatic leak needs
further investigations and treatment. There is currently no systematic review of the diagnostic test accuracy of drain fluid amylase for
the diagnosis of clinically relevant pancreatic leak.
Objectives
To determine the diagnostic accuracy of amylase in drain fluid at 48 hours or more for the diagnosis of pancreatic leak in people who
had undergone pancreatic resection.
Search methods
We searched MEDLINE, Embase, the Science Citation Index Expanded, and the National Institute for Health Research Health
Technology Assessment (NIHR HTA) websites up to 20 February 2017. We searched the references of the included studies to identify
additional studies. We did not restrict studies based on language or publication status, or whether data were collected prospectively or
retrospectively. We also performed a ’related search’ and ’citing reference’ search in MEDLINE and Embase.
Selection criteria
We included all studies that evaluated the diagnostic test accuracy of amylase in the drain fluid at 48 hours or more for the diagnosis of
pancreatic leak in people who had undergone pancreatic resection excluding total pancreatectomy. We planned to exclude case-control
studies because these studies are prone to bias, but did not find any. At least two authors independently searched and screened the
references produced by the search to identify relevant studies.
Data collection and analysis
Two review authors independently extracted data from the included studies. The included studies reported drain fluid amylase on
different postoperative days and measured at different cut-off levels, so it was not possible to perform a meta-analysis using the bivariate
model as planned. We have reported the sensitivity, specificity, post-test probability of a positive and negative drain fluid amylase along
with 95% confidence interval (CI) on each of the different postoperative days and measured at different cut-off levels.
1Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
A total of five studies including 868 participants met the inclusion criteria for this review. The five studies included in this review
reported the value of drain fluid amylase at different thresholds and different postoperative days. The sensitivities and specificities were
variable; the sensitivities ranged between 0.72 and 1.00 while the specificities ranged between 0.73 and 0.99 for different thresholds
on different postoperative days. At the median prevalence (pre-test probability) of 15.9%, the post-test probabilities for pancreatic leak
ranged between 35.9% and 95.4% for a positive drain fluid amylase test and ranged between 0% and 5.5% for a negative drain fluid
amylase test.
None of the studies used the reference standard of confirmation by surgery or by a combination of surgery and clinical follow-up, but
used the International Study Group on Pancreatic Fistula (ISGPF) grade B and C as the reference standard. The overall methodological
quality was unclear or high in all the studies.
Authors’ conclusions
Because of the paucity of data and methodological deficiencies in the studies, we are uncertain whether drain fluid amylase should be
used as a method for testing for pancreatic leak in an unselected population after pancreatic resection; and we judge that the optimal
cut-off of drain fluid amylase for making the diagnosis of pancreatic leak is also not clear. Further well-designed diagnostic test accuracy
studies with pre-specified index test threshold of drain fluid amylase (at three times more on postoperative day 5 or another suitable
pre-specified threshold), appropriate follow-up (for at least six to eight weeks to ensure that there are no pancreatic leaks), and clearly
defined reference standards (of surgical, clinical, and radiological confirmation of pancreatic leak) are important to reliably determine
the diagnostic accuracy of drain fluid amylase in the diagnosis of pancreatic leak.
P L A I N L A N G U A G E S U M M A R Y
Amylase in drain fluid for the diagnosis of pancreatic leak after partial removal of the pancreas
Background
The pancreas is an organ in the abdomen that secretes pancreatic juice that aids digestion; and it contains cells that produce important
hormones such as insulin. Partial removal of the pancreas (pancreatic resection) is performed to remove cancerous and non-cancerous
growths in the pancreas. During this process, new connections (anastomoses) are made between the pancreas and intestines and bile
duct (a tube that transports bile from the liver to the intestines). These connections may break down and result in leakage of pancreatic
content into the abdomen; this can lead to severe infections within the abdomen and in the blood stream, which can even lead to the
death of the patient.
At the end of the operation, a drainage tube is inserted into the abdomen for two purposes: firstly, the detection of any fluid collections
within the abdomen (intra-abdominal collections), usually resulting from the pancreatic leaks; and secondly, as the treatment of intra-
abdominal collections, so that fluid collection decreases or, at least, does not worsen within the abdomen. The fluids from the drain
can be tested for amylase (one of the contents of the pancreatic juice which digests carbohydrates) to find out whether the fluid in the
drain is because of a pancreatic leak. If there is a high suspicion of a pancreatic leak, further scans are performed to confirm it or to rule
it out. If the leak is major and the patient is unwell, urgent reoperation may be required. Moderate leaks can lead to intra-abdominal
infections: patients may need antibiotics, drugs that decrease pancreatic secretion, insertion of a new drainage tube or repositioning of
the existing drainage tube to drain the infected collection, and supportive care to recover. Currently, it is unclear whether measuring
the amylase content in the fluid from the drain inserted after pancreatic resection is useful in identifying pancreatic leaks.
Study characteristics
We performed a thorough literature search for studies reporting the accuracy of drain fluid amylase in identifying pancreatic leaks. We
included studies reported up to 20 February 2017. We identified five studies reporting information on 868 people who underwent
pancreatic resections for cancer and non-cancerous growths. Most studies included only people in whom the head of the pancreas (right
side of the pancreas) was removed.
Key results
Variations in when the studies measured the amylase content in the drain and what level was considered abnormal meant that we
were not able to combine the data to provide the overall results. We are uncertain whether drain fluid amylase is useful in identifying
pancreatic leaks because of the following reasons.
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1. The way that study authors confirmed that a participant had or did not have pancreatic leak was itself subject to error (i.e. there was
no true ’gold standard’).
2. The studies included few participants. As a result, there was significant uncertainty in the results.
3. The studies were of poor methodological quality. This introduced additional uncertainty in the results.
Quality of evidence
All of the studies were of unclear or low methodological quality, which may result in arriving at false conclusions.
B A C K G R O U N D
Please see glossary of terms in Appendix 1.
The pancreas is an abdominal organ that secretes several digestive
enzymes into the pancreatic ductal system that empties into the
small bowel. It also houses the Islets of Langerhans, which secrete
several hormones including insulin (NCBI 2014). Pancreatic re-
section is performed to treat pancreatic diseases, including pancre-
atic cancer, pre-cancerous pancreatic lesions, and chronic pancre-
atitis. Pancreatic resection is in the form of pancreaticoduodenec-
tomy for lesions and disease of the head of the pancreas, and distal
pancreatectomy for lesions in the body and tail of the pancreas
(Park 2013). After pancreaticoduodenectomy, pancreato-enteric
anastomosis is performed to allow the drainage of pancreatic fluid
into the small bowel. After distal pancreatectomy, the cut surface
of the pancreatic remnant (pancreatic stump) is closed using sta-
ples or sutures (Diener 2011). Generally, an abdominal drain is
placed after pancreatic resection, although this practice has been
questioned (van der Wilt 2013).
Pancreatic resection is a surgical procedure with high morbidity.
It carries a postoperative mortality of around 4.5% (Gurusamy
2013). Approximately 30% of patients develop one or more post-
operative complications (Gurusamy 2013). Approximately 18%
of patients develop postoperative pancreatic leak or postoperative
pancreatic fistula (POPF) making it one of the common compli-
cations of pancreatic resection (Gurusamy 2013). POPF is an ab-
normal communication containing enzyme-rich pancreatic fluid
between the pancreatic ductal epithelium and another epithelial
surface. It represents a failure of healing or sealing of the pancre-
ato-enteric anastomosis or it may represent a parenchymal leak
not directly related to an anastomosis, such as a leak from the raw
pancreatic surface after distal pancreatectomy (Bassi 2005). Pan-
creatic leak includes leak of pancreatic fluid or intestinal contents
into the general abdominal cavity. The leak may be self-contained
and minimal or may lead to peritonitis or life-threatening general
sepsis.
Clinically, POPF can be defined as an output via an operatively
placed drain (or a subsequently placed, percutaneous drain) of any
measurable volume of drain fluid on or after postoperative day 3,
with an amylase content greater than three times the upper normal
serum value according to the definition by the International Study
Group on Pancreatic Fistula (ISGPF) (Bassi 2005). Various other
definitions exist (Bassi 2005). ISGPF has graded postoperative
fistulas as Grade A,Grade B, andGrade Cbased on their respective
clinical impact, as shown below and Table 1 (Bassi 2005).
• Grade A: This grade of fistula has no clinical impact and
requires little change in management or deviation from the
normal clinical pathway.
• Grade B: This grade of fistula requires a change in
management or adjustment in the clinical pathway. Many people
with this grade of fistula can be discharged with drains in situ
and observed in the outpatient setting. However, there is no
requirement for an invasive procedure.
• Grade C: This grade of fistula requires a major change in
clinical management or deviation from the normal clinical
pathway. People with this grade of fistula typically require an
extended hospital stay with a major delay in hospital discharge;
and they often undergo reoperation.
Various interventions to decrease postoperative leaks include
pancreaticogastrostomy rather than pancreaticojejunostomy after
pancreatic resections (McKay 2006), somatostatin analogues to
decrease pancreatic fluid secretion (Gurusamy 2013), and fibrin
sealants (in the form of glue (Suzuki 1995) or patches (Montorsi
2012)) to seal the pancreatic stump. Despite one or more of these
measures, approximately 14% of patients develop a pancreatic fis-
tula (Gurusamy 2013).
Target condition being diagnosed
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Clinically significant postoperative pancreatic leak (clinically sig-
nificant pancreatic fistula or other leaks requiring intervention).
Index test(s)
Amylase in drain fluid
Amylase is an enzyme secreted by the pancreas. Various other tis-
sues including salivary glands, small intestines, ovaries, adipose tis-
sue and skeletal muscles secrete amylase. There are two major iso-
forms of amylase - pancreatic amylase and salivary amylase (Vissers
1999). High amylase in the drain fluid indicates pancreatic leak
since the pancreas is the source of pancreatic amylase and without
a leak, the pancreatic fluid drains into the small intestine. Amylase
can be measured by immunochemical assays, usually with mon-
oclonal antibodies (Maeda 2008; Mifflin 1985). The test is con-
ducted by the laboratory technicians and interpreted by the clin-
icians managing the patient. Drain fluid amylase content greater
than three times the upper normal serum value is considered to
be abnormal (Bassi 2005). Normal serum amylase can vary be-
tween laboratories but is usually between 100 IU/L and 300 IU/
L (Vissers 1999).
Clinical pathway
When there is a high suspicion of pancreatic fistula, usually based
on high amylase content of drain fluid, further radiological in-
vestigations such as a computed tomography (CT) scan are per-
formed to identify and subsequently deal with identified pancre-
atic leaks. Grade A POPF is not associated with any peripancre-
atic fluid collections and the patient is clinically well. The ma-
jor difference in management of people with Grade A POPF and
those without pancreatic fistula is the delayed removal of drains.
Grade B POPF may be associated with peripancreatic collections
on CT scan. The patient may require repositioning of the drain
if there is a peripancreatic collection, and usually requires enteral
or parenteral nutritional support. Depending upon the clinical
signs and symptoms such as abdominal pain, fever, and elevated
white cell count, antibiotics and somatostatin analogues may be
required. Grade C POPF is usually associated with peripancreatic
fluid collections on CT scan and these often require reoperation.
Patients with grade B and C POPF usually require enteral or par-
enteral nutritional support, intravenous antibiotics, and somato-
statin analogues, and are usually managed in an intensive therapy
unit setting. If there is clinical deterioration and development of
sepsis and organ dysfunction, reoperation with a view to repair the
site of leakage, conversion to an alternative means of pancreato-
enteric anastomosis (e.g. conversion of pancreaticojejunostomy to
pancreaticogastrostomy), or a complete pancreatectomy may be
necessary. Thus, the presence and grade of pancreatic leak alters
the treatment pathway. This is shown in Figure 1. If there is a high
suspicion of pancreatic leak because of the presence of peritonitis
or sepsis, patients may undergo further radiological investigations
directly, without waiting for the drain fluid amylase measurement.
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Figure 1. Clinical pathway
Prior test(s)
Amylase in the drain fluid (the index test) is usually the first in-
vestigation performed in people with suspected pancreatic leak.
Role of index test(s)
The index test is used to test for pancreatic leak in an unselected
population after pancreatic resection. It is usually followed by CT
scan or magnetic resonance cholangiopancreatography (MRCP)
to confirm the presence or absence of peripancreatic collection and
pancreatic leak. Thus, drain fluid amylase can be considered as a
triage test prior toCT scan orMRCP in the diagnosis of pancreatic
leak.
Rationale
The treatment of patients with clinically significant pancreatic
leaks is different from those without clinically significant pancre-
atic leaks as mentioned in the clinical pathway. It is important
to know the true diagnostic accuracy of drain fluid amylase as a
method for testing for clinically significant pancreatic leak in an
unselected population after pancreatic resection, so that an in-
formed decision can be made as to whether the person with a sus-
pected pancreatic leak needs further investigations. There is cur-
rently no systematic review of the diagnostic test accuracy of amy-
lase in the drain fluid for the diagnosis of pancreatic leak. Hence,
a Cochrane Review of this subject is necessary.
O B J E C T I V E S
To determine the diagnostic accuracy of amylase in drain fluid at
48 hours or more for the diagnosis of pancreatic leak in people
who had undergone pancreatic resection.
Secondary objectives
If we identified heterogeneity, we planned to explore heterogeneity
by using the following sources of heterogeneity as covariate(s) in
the regression model.
1. Studies at low risk of bias in all the domains versus those at
unclear or high risk of bias (as assessed by the QUADAS-2 tool,
recommended by the Cochrane Diagnostic Test Accuracy
Group) (Whiting 2006; Whiting 2011).
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2. Full-text publications versus abstracts (this can give an idea
about publication bias since there may be an association between
the results of the study and the study reaching full publication
status) (Eloubeidi 2001).
3. Prospective studies versus retrospective studies.
4. Pancreatoduodenectomies versus distal pancreatic resection.
5. Participants with cancers versus those with benign diseases.
6. Different reference standards (confirmation by surgical
resection in all participants versus a combination of surgical
resection and clinical follow-up).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all studies that evaluated the diagnostic test accuracy
of amylase in drain fluid for the diagnosis of clinically significant
pancreatic leak in people who had undergone pancreatic resection
excluding total pancreatectomy.We included studies that provided
information on the index test and reference standards irrespective
of language or publication status, or whether the datawas collected
prospectively or retrospectively.However, we excluded case reports
that describe how the diagnosis of pancreatic leak was made on
an individual participant or a group of participants and which
did not provide sufficient diagnostic test accuracy data, i.e. true
positive, false positive, false negative, and true negative. We also
excluded case-control studies because these studies are prone to
bias (Whiting 2011).
Participants
Peoplewhohave undergone pancreatic resectionwith drainfluid at
least 48 hours after pancreatic resection irrespective of the volume
of the drain fluid.
Index tests
Drain fluid amylase.
Target conditions
Clinically significant pancreatic leak (pancreatic leaks that require
radiological or surgical intervention)
Reference standards
We planned to accept one of the following reference standards as
per our review protocol. However, according to these reference
standards we could not have included any studies as none of the
studies reported used one of the two reference standards below.
1. Pancreatic leak confirmed at surgery. This is confirmation
of pancreatic leak at surgery usually on the basis of the presence
of partial or complete separation of the anastomosis allowing
leakage of contents, abdominal collections, or fistula (a tract
between the anastomosis and exterior), and is a subjective
decision made by the surgeon. Nevertheless, this is the best
reference standard available.
2. Pancreatic leak confirmed at surgery for participants with
elevated amylase and clinical follow-up for a minimum period of
six weeks (to ensure that they do not have complications due to
pancreatic leak such as abdominal collections requiring drainage,
intra-abdominal sepsis, generalised sepsis resulting from intra-
abdominal sepsis, or mortality due to intra-abdominal sepsis) in
people with negative amylase. The clinical follow-up should have
included clinical examination of the patient, and may or may not
have included radiological follow-up done as follow-up of
suspected pancreatic leak or routine radiological follow-up to
detect the recurrence of cancer. In retrospective studies, we
accepted hospital records of physical examination of the patient
after a minimum follow-up period of six weeks as an acceptable
reference standard. The presence of one or more complications
due to pancreatic leak such as abdominal collections requiring
drainage, intra-abdominal sepsis, generalised sepsis resulting
from intra-abdominal sepsis, or mortality due to intra-
abdominal sepsis was considered as a positive reference standard.
Because of the lack of any studies using one of the two reference
standards mentioned above, we accepted ISGPF grades B and C
POPF as reference standards. People with grade C POPF require
surgery while those with grade B POPF usually do not undergo
surgery but may require additional radiological drainage (Bassi
2005). These people with grade B POPF do not have systemic
sepsis but have localised intra-abdominal infection. Although the
intra-abdominal infections are usually because of pancreatic leaks
in people undergoing pancreatic resection (these leaks are usually
at least partially ’contained’ (i.e. the effects limited) by the body’s
defence mechanism), one cannot be sure that the intra-abdominal
infection was because of pancreatic leak. So, the reference stan-
dards used in this review might misclassify the target condition of
pancreatic leak.
Search methods for identification of studies
We included all studies irrespective of the language of publication
and publication status. We obtained translations for articles found
in non-English language.
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Electronic searches
We searched the following databases up to 20 February 2017.
1. MEDLINE OvidSP (January 1946 to 20 February 2017)
(Appendix 2).
2. Embase OvidSP (January 1947 to 20 February 2017)
(Appendix 3).
3. Science Citation Index Expanded via Web of Knowledge
(January 1980 to 20 February 2017) (Appendix 4).
4. National Institute for Health Research (NIHR HTA) via
Centre for Reviews and Dissemination (up to 20 February 2017)
(Appendix 5).
Searching other resources
We searched the references of the included studies to identify addi-
tional studies. We also searched for articles related to the included
studies by performing the ’related search’ function in MEDLINE
(OvidSP) and Embase (OvidSP) and a ’citing reference’ search (by
searching the articles which cite the included articles; Sampson
2008) in these two databases.
Data collection and analysis
Selection of studies
Two review authors (TD and KG) independently searched the ref-
erences produced by the search to identify relevant studies. We ob-
tained the full texts of the references that were considered relevant
by at least one of the review authors. Two authors (TD and KG)
independently screened the full-text papers against the inclusion
criteria. We resolved any differences in study selection by discus-
sion. We selected studies that met the inclusion criteria for data
extraction irrespective of the publication status.
Data extraction and management
Two review authors (TD and KG) independently extracted the
following data from each included study using a pre-piloted data
extraction form; the two authors settled any differences by discus-
sion.
1. First author and contact details.
2. Year of publication.
3. Publication status (abstract or full-text).
4. Study design (prospective or retrospective cohort studies;
cross-sectional studies or randomised controlled trials).
5. Inclusion and exclusion criteria for individual studies.
6. Total number of participants.
7. Number of females.
8. Average age of the participants.
9. Proportion of pancreatoduodenectomies.
10. Proportion of participants with cancers.
11. Description of the index test.
12. Threshold used for index test.
13. Reference standard.
14. Number of true positives, false positives, false negatives,
and true negatives (diagnostic test accuracy data).
If the same study reported the index test at different thresholds, we
planned to calculate true positives, false positives, false negatives,
and true negatives for the index test at different thresholds, and
extract this information for each threshold. We excluded partici-
pants with uninterpretable index test results (no matter the reason
given for lack of interpretation, for example low volume of drain
fluid) since in clinical practice, uninterpretable index test results
will result in additional tests such as CT scan for diagnosis of pan-
creatic leak. However, we recorded the number of uninterpretable
index test results as this provides information on the applicability
of the test in clinical practice, and may affect the cost-effectiveness
of a test (the cost-effectiveness is outside the scope of this review;
cost-effectiveness studies may use data from this review). Further
information was sought from study authors if necessary.
Assessment of methodological quality
Two authors (TD and KG) independently assessed study quality
using the QUADAS-2 assessment tool (Whiting 2006; Whiting
2011). We resolved any differences in the methodological quality
assessment by discussion between us until we reached a consensus.
The criteria used for this is shown in Table 2; we decided these a
priori and published them in the protocol (except for the reference
standard, which was revised to include the new reference standard
that we accepted). We considered studies which were classified as
’low risk of bias’ and ’low concern’ in all the domains as studies of
high methodological quality.
Statistical analysis and data synthesis
We plotted study estimates of sensitivity and specificity on for-
est plots and in receiver operating characteristics (ROC) space to
explore variation in the performance of drain fluid amylase due
to differences in threshold. When a study evaluated an increasing
trend in drain fluid amylase values (by repeated testing) in the
same cohort study group, we considered this as the ’threshold’ for
the purpose of this review.
To estimate the summary sensitivity and specificity of drain fluid
amylase at each threshold, we had planned to perform meta-anal-
yses using the bivariate model (Chu 2006; Reitsma 2005). How-
ever, because there were few studies and the studies were performed
on different postoperative days using different thresholds, meta-
analysis was not possible. To summarise the findings from indi-
vidual studies, we estimated median, and lower and upper quar-
tiles of pre-test probabilities across the included studies. Post-test
probabilities were then calculated for each study using these pre-
test probabilities and the positive and negative likelihood ratios
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from the study. The post-test probability associated with a positive
test is the probability of having pancreatic leak following a posi-
tive amylase test result. The post-test probability associated with a
negative test is the probability of having pancreatic leak following
a negative test result.
Investigations of heterogeneity
We had planned to use bivariate meta-regression (adding a co-
variate to a bivariate model) to investigate the following poten-
tial sources of heterogeneity: risk of bias, publication status, type
of recruitment (prospective versus retrospective), type of pancre-
atic resection (pancreatoduodenectomies versus distal pancreatic
resection), different aetiologies, and different reference standards.
We were unable to formally explore heterogeneity as we did not
perform a meta-analysis.
Sensitivity analyses
We did not plan to conduct any sensitivity analyses except when
the data available from the studies were ambiguous (for example,
the numbers in the text are different from the numbers in the
figures); we did not find any such ambiguity in our review.
Assessment of reporting bias
Wedid not explore any of the planned investigation to see whether
the summary sensitivity and specificity were different between
studies that are published as full texts and those that are available
only as abstracts (at least two years prior to the search date). This
is because only one of the included studies was published as an
abstract and the thresholds of index tests were different between
the included studies (Araki 2012).
R E S U L T S
Results of the search
We identified a total number of 2701 references through the elec-
tronic searches of MEDLINE (n = 594), Embase (n = 1695), Sci-
ence Citation Index Expanded (n = 389), and National Institute
for Health Research (NIHR HTA) (n = 23). We excluded 897
duplicates and 1724 clearly irrelevant references through reading
the titles or abstracts, or both. We retrieved full-text articles of
80 references for further assessment against our review protocol
inclusion criteria. Of the 80 references (68 studies), we excluded
73 references (63 studies) for the reasons listed in Characteristics
of excluded studies. Five studies (seven references) fulfilled the
inclusion criteria and provided the diagnostic accuracy data for
the review (Araki 2012; El Nakeeb 2013; Facy 2012; Kong 2008;
Kosaka 2014). We have shown the reference flow in Figure 2.
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Figure 2. Study flow diagram.
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Included studies
All the included studies assessed pancreatic leak following pancre-
atic resection excluding total pancreatectomy. A total of 868 par-
ticipants were analysed in the five included studies. All the stud-
ies except Facy 2012 included only participants who underwent
pancreaticoduodenectomy. The average age of participants in the
studies that reported this information ranged between 53 years
and 67 years; and about a third of participants (32%) were females
in these four studies (El Nakeeb 2013; Facy 2012; Kong 2008;
Kosaka 2014). Except for Araki 2012, which was an abstract, the
remaining four studies were full-text publications. Only two stud-
ies were prospective (Facy 2012; Kong 2008); the remaining three
studies were retrospective studies (Araki 2012; El Nakeeb 2013;
Kosaka 2014).
Excluded studies
A total of 64 studies were excluded at the full-text stage for the
following reasons.
• Not a diagnostic test accuracy study: six studies (Fong
2016; Palani Velu 2015; Ramesh 2006; Sutcliffe 2015; Teixeira
2016; Yang 2015).
• Inappropriate population: three studies (Kanda 2014;
Kobayashi 2015; Mcmillan 2015).
• Inappropriate index test: four studies (Kawai 2011; Kosaka
2013; Kosaka 2014a; Prakash 2011).
• Inappropriate target condition: 20 studies (Cherian 2010;
Cirocchi 2015; Israel 2014; Kumar 2013; Lee 2014; Malleo
2014; Menon 2012; Molinari 2007; Nissen 2012; Partelli 2014;
Raja 2015; Sanchez Acedo 2013; Saxena 2014; Shi 2009;
Shinchi 2006; Shyr 2003; Srivastava 2016; Sutcliffe 2012;
Sutcliffe 2014; Zelga 2015).
• No diagnostic test accuracy data using appropriate reference
standard: 30 studies (Ansorge 2014; Burdy 1999; Ceroni 2014;
Chen 2015; Chhabra 2011; Dugalic 2014; Furukawa 2015;
Gebauer 2012; Graham 2013; Hashimoto 2003; Hashimoto
2014; Hiyoshi 2013; Ho 2014; Kim 2014; Kurahara 2011;
Mimura 2012; Moskovic 2010; Musiewicz 2010; Noji 2012;
Okano 2011; Robinson 2010; Shimizu 2015; Sugimoto 2013;
Tang 2015; Tsujie 2012; Uemura 2011; Uemura 2014; Veillette
2010; Ven Fong 2015; Yamaguchi 2003).
Methodological quality of included studies
The methodological quality of the included studies is shown in
Characteristics of included studies table and a summary of the
methodological quality is shown in Figure 3.
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Figure 3. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study
Participant selection
Three studies had low risk of bias and low applicability concerns
regarding the selection of participants, as these studies included
consecutive patients (El Nakeeb 2013; Kong 2008; Kosaka 2014).
One study had high risk of bias regarding the selection of partici-
pants and unclear applicability concerns because the participants
without lipase tests were excluded (Facy 2012). The remaining
one study was at unclear risk of bias with unclear concerns about
applicability because this study did not mention whether a con-
secutive or random sample of patients was included, and whether
there were any exclusions that we considered inappropriate (Araki
2012).
Index test
Regarding the index test, Facy 2012 andKong 2008were at unclear
risk of bias; and Araki 2012, El Nakeeb 2013 and Kosaka 2014
were at high risk of bias. Three studies, in which it was clear that
the thresholds were based on the ROC curve, were classified as
high risk of bias (Araki 2012; El Nakeeb 2013; Kosaka 2014).
It was not clear whether the index test results were interpreted
without knowledge of the reference standard results in any of the
studies. So, all studies have been classified as unclear or high risk
of bias. All included studies had low concerns about applicability
in the ’index test’ domain because the criteria for positive index
tests were clearly stated in the included studies.
Reference standard
None of the studies were at low risk of bias in this domain. All
included studies were at unclear risk of bias because the reference
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standards used were the ISGPF definition. It was also not clear
whether the reference standards were interpreted without knowl-
edge of the index test results. All studies were at high concern about
applicability. This is because the reference standards used in all
the studies were the ISGPF definitions (grade B or C). There is a
possibility of misclassification of target condition by this reference
standard as detailed in the discussion.
Flow and timing
All the studies were at unclear risk of bias since the studies did not
report the period that they followed up participants to determine
whether they had grade B or C POPF. In addition, it was not clear
whether some participants were excluded prior to analysis in two
studies (Araki 2012; Facy 2012).
Findings
The included studies reported the value of drain fluid amylase
measured on different days and at different thresholds, so a meta-
analysis was not performed. Three studies reported the participant
flow clearly; in these studies, none of the participants has uninter-
pretable results (El Nakeeb 2013; Kong 2008; Kosaka 2014). The
remaining two studies did not report any participants with unin-
terpretable results; however, one cannot rule out uninterpretable
results in these studies since the participant flow was not reported
(Araki 2012; Facy 2012).
The median pre-test probability of clinically significant pancre-
atic leak (proportion with pancreatic leak out of total number
of included participants) was 15.9%, with minimum of 6% and
maximum of 32%. The lower and upper quartiles were 7.6% and
21.5% respectively. The sensitivity and specificity along with the
95% CI for each different threshold on different postoperative
days are shown in forest plot (Figure 4), ROC space (Figure 5),
and in the Summary of findings.
Figure 4. Forest plot of tests: The numbers following POD (postoperative day) indicate the number of the
postoperative day. The numbers or text following DFA (drain fluid amylase) indicate the threshold. The drain
fluid amylase measured on 5th postoperative day using a threshold of more than three times serum amylase
provides the best sensitivity with high specificity. However, this is based on a single study with small sample
size. Another study which used the same threshold between 3 days and 5 days has much less diagnostic test
accuracy introducing significant uncertainty in the findings.
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Figure 5. Plot of sensitivity and specificity in the ROC (receiver operating characteristics) space: The
numbers following POD (postoperative day) indicate the number of the postoperative day. The numbers or
text following DFA (drain fluid amylase) indicate the threshold. The drain fluid amylase measured on 5th
postoperative day using a threshold of more than three times serum amylase provides the best sensitivity with
high specificity. However, this is based on a single study with small sample size. Another study which used the
same threshold between 3 days and 5 days has much less diagnostic test accuracy introducing significant
uncertainty in the findings.
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Drain fluid amylase at a cut-off of greater than 600
IU/L on postoperative day 3
There were 182 participants in the only study with drain fluid
amylase measured on postoperative day 3 using a cut-off level of
more than 600 IU/L (Araki 2012). At this threshold level, the
sensitivity of diagnosing clinically relevant pancreatic leakwas 0.86
(95% CI 0.68 to 0.96) and the specificity was 0.73 (95% CI 0.65
to 0.80).
Drain fluid amylase at a cut-off of greater than three
times serum amylase on postoperative days 3 to 5
There were 65 participants in the only study with drain fluid
amylase measured on postoperative days 3 to 5 using a cut-off
value of more than three times serum amylase level (Facy 2012). At
this cut-off value, the sensitivity of diagnosing clinically significant
pancreatic leak was 0.79 (95% CI 0.49 to 0.95) and its specificity
was 0.78 (95% CI 0.65 to 0.89).
Drain fluid amylase at a cut-off of greater than 647
IU/L on postoperative day 4
There were 100 participants in the only study with a drain fluid
amylase measured on postoperative day 4 using a cut-off value
of more than 647 IU/L (Kosaka 2014). At this cut-off value, the
sensitivity of diagnosing clinically relevant pancreatic leakwas 0.72
(95% CI 0.53 to 0.86) and its specificity was 0.91 (95% CI 0.82
to 0.97).
Drain fluid amylase at a cut-off of greater than three
times serum amylase on postoperative day 5
There were 50 participants in the only study with a drain fluid
amylase measured on postoperative day 5 using a cut-off value
of more than three times serum amylase level (Kong 2008). At
this cut-off value, the sensitivity of diagnosing clinically relevant
pancreatic leak was 1.00 (95% CI 0.29 to 1.00) and the specificity
of this index test was 0.94 (95% CI 0.82 to 0.99).
Drain fluid amylase at a cut-off of greater than 4000
IU/L on postoperative day 5
There were 471 participants in the only study with drain fluid
amylase measured on postoperative day 5 using a cut-off value
of more than 4000 IU/L (El Nakeeb 2013). At this cut-off level,
the sensitivity of clinically significant pancreatic leak diagnostic
accuracy was 0.75 (95% CI 0.58 to 0.88) and the specificity was
0.99 (95% CI 0.98 to 1.00).
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Summary of findings
Population People undergoing pancreat ic resect ion
Setting Secondary care in various countries
Target condi-
tion
Clinically signif icant pancreat ic leak
Reference
standard
Internat ional Study Group on Pancreat ic Fistula (ISGPF) grade B or C
M edian preva-
lence of pan-
creatic leak
15.9%
Index test1 Sensitivity Specificity Post- test prob-
ability of a pos-
itive test2
Post- test prob-
ability of a neg-
ative test2
Number of
studies
Number of par-
ticipants
Risk of bias Applicability
concerns
Plain language
interpretation
POD:3 DFA >
600 IU/ L
0.86 (95% CI 0.
68 to 0.96)
0.73 (95% CI 0.
65 to 0.80)
37.9% (95% CI
31.1%to 45.1%)
3.4% (95% CI 1.
4% to 8.2%)
1 182 Unclear High At the median
pre-test probabil-
ity of 16%, out of
100 people with
posit ive test, 38
people (95% CI
31 to 45) have
clinically signif -
icant pancreat ic
leak. At the same
pre-test probabil-
ity, out of 100
people with neg-
at ive test, 3 peo-
ple (95% CI 1
to 8) have clin-
ically signif icant
pancreat ic leak15
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POD:3 to 5 DFA
> 3 times serum
amylase
0.79 (95% CI 0.
49 to 0.95)
0.78 (95% CI 0.
65 to 0.89)
40.8% (95% CI
27.7%to 55.5%)
4.9% (1.8% to
12.5%)
1 65 High High At the median
pre-test probabil-
ity of 16%, out of
100 people with
posit ive test, 41
people (95% CI
28 to 56) have
clinically signif -
icant pancreat ic
leak. At the same
pre-test probabil-
ity, out of 100
people with neg-
at ive test, 5 peo-
ple (95% CI 2
to 13) have clin-
ically signif icant
pancreat ic leak
POD:4 DFA >
647 U/ L
0.72 (95% CI 0.
53 to 0.86)
0.91 (95% CI 0.
82 to 0.97)
60.7% (95% CI
41.1%to 77.4%)
5.5% (95% CI 3.
2% to 9.3%)
1 100 High High At the median
pre-test probabil-
ity of 16%, out of
100 people with
posit ive test, 61
people (95% CI
41 to 77) have
clinically signif -
icant pancreat ic
leak. At the same
pre-test probabil-
ity, out of 100
people with neg-
at ive test, 6 peo-
ple (95% CI 3
to 9) have clin-
ically signif icant
pancreat ic leak1
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POD:5 DFA >
3 times serum
amylase
1.00 (95% CI 0.
29 to 1.00)
0.94 (95% CI 0.
82 to 0.99)
74.8% (95% CI
49.8%to 89.9%)
0% (95% CI not
est imable)
1 50 Unclear High At the median
pre-test probabil-
ity of 16%, out of
100 people with
posit ive test, 75
people (95%CI 50
to 90) have clin-
ically signif icant
pancreat ic leak. It
was not possible
to est imate the
number of people
with clinically sig-
nif icant pancre-
at ic leak when the
test was negat ive
POD:5 DFA >
4000 U/ L
0.75 (95% CI 0.
58 to 0.88)
0.99 (95% CI 0.
98 to 1.00)
95.4% (95% CI
86.8%to 98.5%)
4.6% (95% CI 2.
6% to 7.8%)
1 471 High High At the median
pre-test probabil-
ity of 16%, out of
100 people with
posit ive test, 95
people (95% CI
87 to 99) have
clinically signif -
icant pancreat ic
leak. At the same
pre-test probabil-
ity, out of 100
people with neg-
at ive test, 5 peo-
ple (95% CI 3
to 8) have clin-
ically signif icant
pancreat ic leak
1
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Interpretation The drain f luid amylase measured on 5th postoperat ive day using a threshold of more than three t imes serum amylase provides the best sensit ivity with high
specif icity. A negat ive test more or less rules out pancreat ic leak. However, this is based on a single study with small sample size. Another study which used
the same threshold between 3 days and 5 days has much less diagnost ic test accuracy introducing signif icant uncertainty in the f indings
1The numbers following POD (postoperat ive day) indicate the number of the postoperat ive day. The numbers or text following
DFA (drain f luid amylase) indicate the threshold.
2All post-test probabilit ies were calculated at the median prevalence (pre-test probability) of pancreat ic leak in the studies.
At the lower quart ile of the prevalence of 7.6%, the post-test probabilit ies of pancreat ic leak of posit ive POD:3 DFA > 600 IU/
L, POD:3 to 5 DFA > 3 times serum amylase, POD:4 DFA > 647 U/ L, POD:5 DFA > 3 times serum amylase, and POD:5 DFA >
4000 U/ L were 21.0% (95% CI 16.5% to 26.4%), 23.2% (95% CI 14.3% to 35.2%), 40.3% (95% CI 23.4% to 59.9%), 56.5% (95% CI
30.3% to 79.5%), and 90.0% (95% CI 74.2% to 96.6%) respect ively. At the same pre-test probability, the post-test probabilit ies
of pancreat ic leak of negat ive POD:3 DFA > 600 IU/ L, POD:3 to 5 DFA > 3 times serum amylase, POD:4 DFA > 647 U/ L, POD:
5 DFA > 3 times serum amylase, and POD:5 DFA > 4000 U/ L were 1.5% (95% CI 0.6% to 3.7%), 2.2% (95% CI 0.8% to 5.9%),
2.5% (95% CI 1.4% to 4.3%), 0% (95% CI not est imable), and 2.0% (95% CI 1.2% to 3.5%) respect ively. At the upper quart ile of
the prevalence of 21.5%, the post-test probabilit ies of pancreat ic leak of posit ive POD:3 DFA > 600 IU/ L, POD:3 to 5 DFA > 3
times serum amylase, POD:4 DFA > 647 U/ L, POD:5 DFA > 3 times serum amylase, and POD:5 DFA > 4000 U/ L were 46.9%
(95% CI 39.6% to 54.4%), 50.0% (95% CI 35.7% to 64.3%), 69.1% (95% CI 50.3% to 83.2%), 81.1% (95% CI 59.0% to 92.8%), and
96.8% (95% CI 90.5% to 98.9%) respect ively. At the same pre-test probability, the post-test probabilit ies of pancreat ic leak of
negat ive POD:3 DFA > 600 IU/ L, POD:3 to 5 DFA > 3 times serum amylase, POD:4 DFA > 647 U/ L, POD:5 DFA > 3 times serum
amylase, and POD:5 DFA > 4000 U/ L were 4.9% (95% CI 2.0% to 11.4%), 7.0% (95% CI 2.7% to 17.1%), 7.8% (95% CI 4.6% to
12.9%), 0% (95% CI not est imable), and 6.5% (95% CI 3.8% to 10.8%) respect ively.
CI = conf idence intervals
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D I S C U S S I O N
Summary of main results
A total of five studies including 868 participants met the inclusion
criteria for this review (Araki 2012; El Nakeeb 2013; Facy 2012;
Kong 2008; Kosaka 2014). The median prevalence of clinically
significant POPF (grades B and C) was 15.9%.
The five studies included in this review reported the value of drain
fluid amylase at different thresholds and different postoperative
days. We were unable to perform any meta-analysis or exploration
of heterogeneity because of paucity of data. The sensitivities and
specificities were variable: the sensitivities ranged between 0.72
and 1.00 while the specificities ranged between 0.73 and 0.99
for different thresholds on different postoperative days. At the
median prevalence (pre-test probability) of 15.9%, themean post-
test probabilities for pancreatic leak ranged between 35.9% and
95.4% for a positive drain fluid amylase test and ranged between
0% and 5.5% for a negative drain fluid amylase test.
Strengths and weaknesses of the review
Strengths
One of the main strengths of this review was that we searched the
literature thoroughly, without any publication or language restric-
tions. We did not use any diagnostic test accuracy filters in our
literature search because filters of this kind could lead to exclusion
of some relevant studies (Doust 2005). Inclusion of abstracts and
non-English articlesmay decrease the impact of publication bias to
a certain extent although the determinants and extent of publica-
tion bias and selective reporting are not well known for diagnostic
accuracy studies. We also planned to exclude case-control studies
because these studies are prone to bias (Whiting 2011). Two re-
view authors (TD and KG) independently searched the references
produced by the search to identify relevant studies, screened the
full-text papers against the inclusion criteria and extracted data.
Data extractions by two authors potentially reduce the errors re-
lated to a single author data extraction (Buscemi 2006). Another
strength of this review is that we used the recommended method-
ological quality methods to assess the risk of bias and applicability
concerns in the included studies and took these into consideration
while interpreting the evidence.
Weaknesses
There were several shortcomings in our review. First and foremost
is the change of reference standard. In the protocol, we stated that
we would use either surgical confirmation of presence or absence
of pancreatic leak in all participants or at least surgical confirma-
tion of presence or absence of pancreatic leak in participants with
positive drain fluid amylase and clinical follow-up in those with
negative drain fluid amylase. We did not identify any studies that
used either of these reference standards. So, we have accepted IS-
GPF grades B and C POPF as reference standards. While grade
C POPF equates to surgical confirmation of presence of pancre-
atic leak, grade B POPF includes only POPF that do not require
reoperation. However, grade B POPF includes POPF with intra-
abdominal infection and drainage usually persists for more than
three weeks. Although persistent drainage of POPF can be man-
aged by discharging the patient home with a drain with intermit-
tent follow-up visits to the hospital, it is likely to have a signif-
icant impact on return to work. So, there is no controversy on
whether grade B POPF is clinically significant; the controversy
is whether these are caused by pancreatic leaks. Pancreatic leak is
the major cause of intra-abdominal infection in people who un-
dergo pancreatic resections. However, one cannot be absolutely
sure that there was a clinically significant pancreatic leak in people
with grade B POPF. While major aspects of treatment in people
with grade B POPF is the same as that of confirmed pancreatic
leaks not requiring reoperation but causing intra-abdominal col-
lections (minimally invasive drainage, antibiotics, and supportive
treatment), knowing whether the fistula is due to pancreatic leak
may help in deciding whether patients require interventions such
as somatostatin analogues to decrease the pancreatic secretion. So,
it is useful to distinguish the cause of grade B POPF. By using
grade B or C POPF, there is a possibility of misclassification of the
target condition (pancreatic leak) by the reference standards used
(grade B or C POPF), i.e. some people without pancreatic leak
may have been classified as having pancreatic leak by the reference
standards used. The use of grade C POPF alone as reference stan-
dards would have resulted in an error in the opposite direction, i.e.
some people with clinically significant pancreatic leak may have
beenmisclassified as not having pancreatic leak. However, we were
not able to test the diagnostic accuracy of the index test using
grade C POPF as the reference standards since none of the studies
reported diagnostic test accuracy data using grade C POPF alone
as reference standards. While we agree that surgical confirmation
cannot be performed in everyone with suspected pancreatic leak,
one can expect that surgical confirmation can be performed in
people with high suspicion of pancreatic leak based on the index
test (drain pancreatic amylase) and clinical follow-up for at least
six weeks in those with low suspicion of pancreatic leak based on
the index test (drain pancreatic amylase). Because of lack of these
appropriate reference standards (and use of grade B or C as refer-
ence standards), there is a possibility of underestimation or over-
estimation of diagnostic accuracy of the index test.
Second, there were other methodological deficiencies besides the
bias and concern related to reference standards. For example, three
studies did not pre-specify the drain fluid amylase threshold (Araki
2012; El Nakeeb 2013; Kosaka 2014); this would have resulted in
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overestimation of the diagnostic test accuracy. In addition, none
of the studies reported whether the index tests and references stan-
dards were interpreted independent of each other. If they were
not interpreted independent of each other, the accuracy of the
tests would have been overestimated. None of the studies reported
whether the participants were followed up for sufficient period of
time to rule out grade B or C POPF. This could cause underesti-
mation or overestimation of the diagnostic accuracy.
Third, the sample sizes in most of the studies were small, result-
ing in wide confidence intervals. It was not possible to perform
a meta-analysis since the studies reported drain fluid amylase on
different postoperative days using different thresholds. Addition-
ally, the measurement of drain fluid amylase on different postop-
erative days using different thresholds for diagnosis of pancreatic
leak made it impossible for us to explore whether the results could
be replicated in another group of people.
Comparison with other reviews
We identified two systematic reviews which evaluated the ability
of drain fluid amylase on postoperative day 1 to predict the de-
velopment of pancreatic fistula (Giglio 2016; Lu 2016); and one
systematic review which included drain fluid amylase measured
at any time in the diagnosis of any POPF (Yang 2015). All these
studies concluded that drain fluid amylase on the first postopera-
tive day is a good predictor of development of pancreatic fistula.
However, the objectives of this review were different; we wanted to
evaluate the role of drain fluid amylase in the diagnosis of clinically
significant pancreatic leak. We were unable to find any systematic
reviews addressing this question.
Applicability of findings to the review question
Generalisability of the results
Most of the participants included in this review were people who
underwent pancreaticoduodenectomy surgery for benign and ma-
lignant conditions involving the pancreas. So, the findings of this
review are applicable only for those undergoing pancreaticoduo-
denectomy.
Use of the test in clinical setting
The main role of the index test is as a triage test to identify people
who require further scanning such as CT or MRI. Such a test
needs to be a highly sensitive test, so that it is possible to rule out
pancreatic leak, which will result in avoidance of further testing
and allow the drain to be removed. Themedian prevalence of grade
B or C POPF in the studies included in the reviewwas 15.9%. The
mean post-test probabilities of pancreatic leakwhen the drain fluid
amylase was negative ranged between 0% and 5.5%. However, the
confidence intervals in these studies were higher and these ranged
between 0% and 12.5%. Adding to this uncertainty were random
errors resulting from small sample sizes: these generated a lot of
systematic errors, resulting in further uncertainty. Because of these
uncertainties, the role of drain fluid amylase in the diagnosis of
pancreatic leak in people who undergo pancreatic resection is not
clear.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Because of the paucity of data and methodological deficiencies in
the studies, it is not possible to arrive at any definitive conclusions
i.e. there is no clear evidence whether clinicians should continue to
use drain fluid amylase as a method for testing for clinically signif-
icant pancreatic leak in an unselected population after pancreatic
resection; the optimal cut-off of drain fluid amylase for making
the diagnosis of pancreatic leak is also not clear.
Implications for research
Further well-designed diagnostic test accuracy studies with a pre-
specified index test threshold of drain fluid amylase (at three times
more on postoperative day 5 or another suitable pre-specified
threshold), appropriate follow-up (for at least six to eight weeks
to ensure that there are no pancreatic leaks), and clearly defined
reference standard (of surgical, clinical, and radiological confirma-
tion of pancreatic leak) are important to determine the diagnostic
accuracy of drain fluid amylase reliably.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Araki 2012
Study characteristics Study characteristics
Patient sampling Type of study: retrospective study.
Consecutive or random sample: unclear.
Patient characteristics and set-
ting
Sample size: 182.
Females: not stated.
Age: not stated.
Presentation: people who underwent pancreaticoduodenectomy in a single center in Japan between
April 2003 and May 2012 were included.
Setting: secondary care, Japan.
Index tests Index test: postoperative day 3 drain fluid amylase.
Further details:
Technical specifications: not stated.
Performed by: not stated.
Criteria for positive diagnosis: > 600 IU/L.
Target condition and reference
standard(s)
Target condition: clinically significant pancreatic leak.
Reference standard: ISGPF grade B or C.
Further details:
Technical specifications: not applicable.
Performed by: clinicians.
Criteria for positive diagnosis: ISGPF definitions.
Flow and timing Number of indeterminates for whom the results of reference standard was available: 0 (0%).
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Araki 2012 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Did all patients receive a refer-
ence standard?
Yes
Unclear High
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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El Nakeeb 2013
Study characteristics Study characteristics
Patient sampling Type of study: retrospective study.
Consecutive or random sample: consecutive sample.
Patient characteristics and set-
ting
Sample size: 471.
Females: 193 (41.0%).
Age: 53 years.
Presentation: people who underwent pancreaticoduodenectomy from January 2001 to June 2012
were included.
Setting: secondary care, Egypt.
Index tests Index test: postoperative day 5 drain fluid amylase.
Further details:
Technical specifications: not stated.
Performed by: not stated.
Criteria for positive diagnosis: > 4000 U/L.
Target condition and reference
standard(s)
Target condition: clinically significant pancreatic leak.
Reference standard: ISGPF grade B or C.
Further details:
Technical specifications: not applicable.
Performed by: clinicians.
Criteria for positive diagnosis: ISGPF definitions.
Flow and timing Number of indeterminates for whom the results of reference standard was available: 0 (0%).
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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El Nakeeb 2013 (Continued)
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Did all patients receive a refer-
ence standard?
Yes
Unclear High
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
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Facy 2012
Study characteristics Study characteristics
Patient sampling Type of study: prospective study.
Consecutive or random sample: neither.
Patient characteristics and set-
ting
Sample size: 65.
Females: 31 (47.69%).
Age: 62 years.
Presentation: people who underwent pancreatic resection between 2008 and 2010 and had the
concentration of amylase and lipase measured in abdominal drains were included. People who
underwent total pancreatectomy were not included. People in whom the lipase concentration was
not measured were excluded from analysis.
Setting: tertiary care, France.
Index tests Index test: post operative day 3 to 5 drain fluid amylase.
Further details:
Technical specifications: Dimension Vista Colorimetric Analyser.
Performed by: Dr David Masson.
Criteria for positive diagnosis: 3 times normal limit.
Target condition and reference
standard(s)
Target condition: clinically significant pancreatic leak.
Reference standard: ISGPF grade B or C.
Further details:
Technical specifications: not applicable.
Performed by: clinicians.
Criteria for positive diagnosis: ISGPF definitions.
Flow and timing Number of indeterminates for whom the results of reference standard was available: 0 (0%).
Number of participants who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Facy 2012 (Continued)
High Unclear
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Did all patients receive a refer-
ence standard?
Yes
Unclear High
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Kong 2008
Study characteristics Study characteristics
Patient sampling Type of study: prospective study..
Consecutive or random sample: consecutive patients.
Patient characteristics and set-
ting
Sample size: 50.
Females: 15 (30%).
Age: 67 years.
Presentation: people who underwent modified extended pancreaticoduodenectomy for a peri-
ampullary tumour between April 2004 and August 2006 at two hospitals in Australia were included.
Setting: secondary and tertiary care, Australia.
Index tests Index test: postoperative day 5 drain fluid amylase.
Further details:
Technical specifications: Roche Modular System and Roche Reagent Assays.
Performed by: not stated.
Criteria for positive diagnosis: > 125 u/ml (3 times serum amylase and 50 mls/24 h on D5)
Target condition and reference
standard(s)
Target condition: clinically significant pancreatic leak.
Reference standard: ISGPF grade B or C.
Further details:
Technical specifications: not applicable.
Performed by: clinicians.
Criteria for positive diagnosis: ISGPF definitions.
Flow and timing Number of indeterminates for whom the results of reference standard was available: 0 (0%).
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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Kong 2008 (Continued)
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Did all patients receive a refer-
ence standard?
Yes
Unclear High
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
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Kosaka 2014
Study characteristics Study characteristics
Patient sampling Type of study: retrospective study.
Consecutive or random sample: consecutive patients.
Patient characteristics and set-
ting
Sample size: 100.
Females: 36 (36%).
Age: 67 years.
Presentation: people who underwent pancreaticoduodenectomy between January 2009 andOctober
2012 were included.
Setting: secondary care, Japan.
Index tests Index test: postoperative day 4 drain fluid amylase
Further details:
Technical specifications: not stated.
Performed by: not stated.
Criteria for positive diagnosis: 647 U/L.
Target condition and reference
standard(s)
Target condition: clinically significant pancreatic leak.
Reference standard: ISGPF grade B or C.
Further details:
Technical specifications: not applicable.
Performed by: clinicians.
Criteria for positive diagnosis: ISGPF definitions
Flow and timing Number of indeterminates for whom the results of reference standard was available: 0 (0%).
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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Kosaka 2014 (Continued)
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Did all patients receive a refer-
ence standard?
Yes
Unclear High
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
ISGPF = International Study Group on Pancreatic Fistula
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ansorge 2014 No diagnostic test accuracy data using appropriate reference standard
Burdy 1999 No diagnostic test accuracy data using appropriate reference standard
Ceroni 2014 No diagnostic test accuracy data using appropriate reference standard
Chen 2015 No diagnostic test accuracy data using appropriate reference standard
Cherian 2010 Inappropriate target condition (target condition not defined adequately)
Chhabra 2011 No diagnostic test accuracy data using appropriate reference standard
Cirocchi 2015 Inappropriate target condition
Dugalic 2014 No diagnostic test accuracy data using appropriate reference standard
Fong 2016 Not a diagnostic test accuracy study.
Furukawa 2015 No diagnostic test accuracy data using appropriate reference standard
Gebauer 2012 No diagnostic test accuracy data using appropriate reference standard
Graham 2013 No diagnostic test accuracy data using appropriate reference standard
Hashimoto 2003 No diagnostic test accuracy data using appropriate reference standard
Hashimoto 2014 No diagnostic test accuracy data using appropriate reference standard
Hiyoshi 2013 No diagnostic test accuracy data using appropriate reference standard
Ho 2014 No diagnostic test accuracy data using appropriate reference standard
Israel 2014 Inappropriate target condition
Kanda 2014 Inappropriate population (patients without pancreatic fistula were excluded from the study)
Kawai 2011 Inappropriate index test (drain fluid amylase was measured on post-operative day 1 only)
Kim 2014 No diagnostic test accuracy data using appropriate reference standard
Kobayashi 2015 Inappropriate population (not in patients undergoing pancreatic resection)
Kosaka 2013 Inappropriate index test (not on drain fluid amylase)
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(Continued)
Kosaka 2014a Inappropriate index test
Kumar 2013 Inappropriate target condition
Kurahara 2011 No diagnostic test accuracy data using appropriate reference standard
Lee 2014 Inappropriate target condition
Malleo 2014 Inappropriate target condition
Mcmillan 2015 Inappropriate population (people with amylase > 5000 IU were initially excluded; in addition, people with
low unvalidated fistula risk score were excluded from the analysis)
Menon 2012 Inappropriate target condition
Mimura 2012 No diagnostic test accuracy data using appropriate reference standard
Molinari 2007 Inappropriate target condition
Moskovic 2010 No diagnostic test accuracy data using appropriate reference standard
Musiewicz 2010 No diagnostic test accuracy data using appropriate reference standard
Nissen 2012 Inappropriate target condition
Noji 2012 No diagnostic test accuracy data using appropriate reference standard
Okano 2011 No diagnostic test accuracy data using appropriate reference standard
Palani Velu 2015 Not a diagnostic test accuracy study
Partelli 2014 Inappropriate target condition
Prakash 2011 Inappropriate index test
Raja 2015 Inappropriate target condition
Ramesh 2006 Not a diagnostic test accuracy study
Robinson 2010 No diagnostic test accuracy data using appropriate reference standard
Sanchez Acedo 2013 Inappropriate target condition
Saxena 2014 Inappropriate target condition
Shi 2009 Inappropriate target condition
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(Continued)
Shimizu 2015 No diagnostic test accuracy data using appropriate reference standard
Shinchi 2006 Inappropriate target condition
Shyr 2003 Inappropriate target condition
Srivastava 2016 Inappropriate target condition.
Sugimoto 2013 No diagnostic test accuracy data using appropriate reference standard
Sutcliffe 2012 Inappropriate target condition
Sutcliffe 2014 Inappropriate target condition
Sutcliffe 2015 Not a diagnostic test accuracy study
Tang 2015 No diagnostic test accuracy data using appropriate reference standard
Teixeira 2016 Not a diagnostic test accuracy study
Tsujie 2012 No diagnostic test accuracy data using appropriate reference standard
Uemura 2011 No diagnostic test accuracy data using appropriate reference standard
Uemura 2014 No diagnostic test accuracy data using appropriate reference standard
Veillette 2010 No diagnostic test accuracy data using appropriate reference standard
Ven Fong 2015 No diagnostic test accuracy data using appropriate reference standard
Yamaguchi 2003 No diagnostic test accuracy data using appropriate reference standard
Yang 2015 Not a diagnostic test accuracy study (systematic review)
Zelga 2015 Inappropriate target condition
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 POD:3 DFA > 600 IU/L 1 182
2 POD:3 to 5 DFA > 3 times
serum amylase
1 65
3 POD:4 DFA > 647 U/L 1 100
4 POD:5 DFA > 3 times serum
amylase
1 50
5 POD:5 DFA > 4000 U/L 1 471
Test 1. POD:3 DFA > 600 IU/L.
Review: Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Test: 1 POD:3 DFA > 600 IU/L
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Araki 2012 25 41 4 112 0.86 [ 0.68, 0.96 ] 0.73 [ 0.65, 0.80 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. POD:3 to 5 DFA > 3 times serum amylase.
Review: Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Test: 2 POD:3 to 5 DFA > 3 times serum amylase
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Facy 2012 11 11 3 40 0.79 [ 0.49, 0.95 ] 0.78 [ 0.65, 0.89 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 3. POD:4 DFA > 647 U/L.
Review: Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Test: 3 POD:4 DFA > 647 U/L
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kosaka 2014 23 6 9 62 0.72 [ 0.53, 0.86 ] 0.91 [ 0.82, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 4. POD:5 DFA > 3 times serum amylase.
Review: Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Test: 4 POD:5 DFA > 3 times serum amylase
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kong 2008 3 3 0 44 1.00 [ 0.29, 1.00 ] 0.94 [ 0.82, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 5. POD:5 DFA > 4000 U/L.
Review: Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Test: 5 POD:5 DFA > 4000 U/L
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
El Nakeeb 2013 27 3 9 432 0.75 [ 0.58, 0.88 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A D D I T I O N A L T A B L E S
Table 1. International study group postoperative pancreatic fistula
Grade A B C
Clinical conditions Well Often well Usually ill
Ultrasound/CT (computed to-
mogram) (if obtained)
Negative Negative/positive Positive
Persistent drainage (after 3
weeks)
No Usually yes Yes
Reoperation No No Yes
Death related to postoperative
pancreatic fistula
No No Possibly yes
Signs of infections No Yes Yes
Sepsis No No Yes
Readmission No Yes/no Yes/no
Modified from Bassi 2005.
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Table 2. QUADAS-2 classification
Domain 1: Patient selection Patient sampling Patients who have undergone pancreatic re-
section with drain fluid at least 48 hours
after pancreatic resection irrespective of the
volume of the drain fluid
Was a consecutive or random sample of pa-
tients enrolled?
Yes: if a consecutive sample or a random
sample of patientswith pancreatic resection
with drain fluid at least 48 hours after pan-
creatic resection was included in the study.
No: if a consecutive sample or a random
sample of patientswith pancreatic resection
with drain fluid at least 48 hours after pan-
creatic resection was not included in the
study.
Unclear: if this information was not avail-
able.
Was a case-control design avoided? Yes: if a cohort of patients with pancreatic
resection with drain fluid at least 48 hours
after pancreatic resection was studied.
No: if patients with pancreatic leak were
compared with patients without pancreatic
leak (controls).We planned to exclude such
studies.
Unclear: as anticipated, we were able to de-
termine whether the design was case-con-
trol. There were no case-control studies.
Hence, as anticipated, all studies included
in the review were classified as ’yes’ for this
item
Did the study avoid inappropriate exclu-
sions?
Yes: if all patients with pancreatic resection
with drain fluid at least 48 hours after pan-
creatic resection were included.
No: if the study excluded patients based on
high or low probability of pancreatic leak
(for example, those with high volume in the
drain).
Unclear: if this information was not avail-
able.
Could the selection of patients have intro-
duced bias?
Low risk of bias: if ’yes’ classification for all
of the above 3 questions
High risk of bias: if ’no’ classification for
any of the above 3 questions
Unclear risk of bias: if ’unclear’ classifica-
tion for any of the above 3 questions but
without a ’no’ classification for any of the
above 3 questions
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Table 2. QUADAS-2 classification (Continued)
Patient characteristics and setting Yes: if all patients with pancreatic resection
with drain fluid at least 48 hours after pan-
creatic resection were included.
No: if some patients with pancreatic resec-
tion with drain fluid at least 48 hours after
pancreatic resection were excluded on the
basis of the results of drain fluid volume.
Unclear: if it was not clear whether the pa-
tients had been included on the basis of the
results of drain fluid volume
Are there concerns that the included pa-
tients and setting do not match the review
question?
Low concern: if the patient characteristics
and setting were classified as ’yes’
Unclear concern: if the patient characteris-
tics and setting were classified as ’unclear’
High concern: if the patient characteristics
and setting were classified as ’no’
Domain 2: Index test Index test(s) Amylase in drain fluid.
Were the index test results interpretedwith-
out knowledge of the results of the refer-
ence standard?
The index test would always be conducted
though not interpreted before the reference
standard
Yes: if the index test was conducted and
interpreted without the knowledge of the
results of the reference standard.
No: if the index test was interpreted with
the knowledge of the results of the reference
standard.
Unclear: if it was not clear whether the in-
dex test was interpreted without the knowl-
edge of the results of the reference standard
If a thresholdwas used, was it pre-specified? Yes: if a pre-specified threshold was used.
No: if a pre-specified threshold was not
used.
Unclear: if it was not clear whether the
threshold used was pre-specified
Could the conduct or interpretation of the
index test have introduced bias?
Low risk of bias: if ’yes’ classification for
both of the above questions
High risk of bias: if ’no’ classification for
any of the above 2 questions
Unclear risk of bias: if ’unclear’ classifica-
tion for any of the above 2 questions but
without a ’no’ classification for any of the
above 2 questions
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Table 2. QUADAS-2 classification (Continued)
Are there concerns that the index test, its
conduct, or interpretation differ from the
review question?
Low concern: if the criteria for positive in-
dex test was clearly stated
High concern: if the criteria for positive
index test was not stated
Domain 3: Target condition and refer-
ence standard
Target condition and reference standard(s) Target condition: clinically significant pan-
creatic leak (requiring clinical intervention)
Planned reference standards (see below).
1. Pancreatic leak confirmed at surgery.
2. Pancreatic leak confirmed at surgery
for patients with elevated amylase and
clinical follow-up for a minimum period
of 6 weeks (to ensure that they do not
have complications due to pancreatic leak
such as abdominal collections requiring
drainage, intra-abdominal sepsis, or
generalised sepsis) in people with negative
amylase.
Is the reference standard(s) likely to cor-
rectly classify the target condition?
Yes: if pancreatic leak was confirmed at re-
operation.
No: if the reference standard was a combi-
nation of pancreatic leak and clinical fol-
low-up for a minimum period of 6 weeks
(to ensure that they do not have compli-
cations due to pancreatic leak such as ab-
dominal collections requiring drainage, in-
tra-abdominal sepsis, or generalised sepsis)
in people with negative amylase
Unclear: although we planned to exclude
studies if the reference standard was not
described adequately or was not one of
the above planned reference standards, this
would have meant that there would have
been no studies included in the review. So,
we accepted the ISGPF grades B and C as
an appropriate references standard and clas-
sified the answer to this signalling question
as unclear
Were the reference standard results inter-
preted without knowledge of the results of
the index tests?
Yes: if the reference standard was inter-
pretedwithout the knowledge of the results
of the index test.
No: if the reference standard was inter-
preted with the knowledge of the results of
the index test.
Unclear: it is not clear if the reference stan-
dard was interpreted without the knowl-
edge of the results of the index test
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Table 2. QUADAS-2 classification (Continued)
Could the reference standard, its conduct,
or its interpretation have introduced bias?
Low risk of bias: if ’yes’ classification for
both of the above 2 questions
High risk of bias: if ’no’ classification for
any of the above 2 questions
Unclear risk of bias: if ’unclear’ classifica-
tion for any of the above 2 questions but
without a ’no’ classification for any of the
above 2 questions
Are there concerns that the target condition
as defined by the reference standard does
not match the question?
Although we anticipated that all of the in-
cluded studies would be classified as ’low
concern’ because of the reference standards
we planned to use, we have classified all the
studies as ’high concern’ because of the ref-
erence standards that we accepted
Domain 4: Flow and timing Flow and timing Patientsmay have progression or resolution
of pancreatic leak if there is a long delay
between index test and reference standard.
An arbitrary 2 weeks was chosen as an ac-
ceptable delay between index test and ref-
erence standard
Was there an appropriate interval between
index test and reference standard?
Yes: if the time interval between index
test and reference standard was less than 2
weeks.
No: if the time interval between index test
and reference standard was more than 2
weeks.
Unclear: if the time interval between index
test and reference standard was unclear
Did all patients receive a reference stan-
dard?
Yes: if all patients received a reference stan-
dard.
No: if some of the patients did not receive
a reference standard. Such studies were ex-
cluded.
Unclear: if it was not clear whether all pa-
tients received a reference standard. Such
studies were excluded. As anticipated, all
studies included in the review were classi-
fied as ’yes’ for this item
Did all patients receive the same reference
standard?
Yes: if all the patients received the same ref-
erence standard.
No: if different patients received different
reference standards
Unclear: if this information was not clear.
Because of the inclusion criteria, all the
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Table 2. QUADAS-2 classification (Continued)
studies in this review were classified as ’yes’
for this signalling question
Were all patients included in the analysis? Yes: if all the patients are included in the
analysis irrespective of whether the results
were interpretable.
No: if some patients are excluded from the
analysis because of uninterpretable results.
Unclear: if this information is not clear.
Could the patient flow have introduced
bias?
Low risk of bias: if ’yes’ classification for all
the above 4 questions
High risk of bias: if ’no’ classification for
any of the above 4 questions
Unclear risk of bias: if ’unclear’ classifica-
tion for any of the above 4 questions but
without a ’no’ classification for any of the
above 4 questions
ISGPF = International Study Group on Pancreatic Fistula
A P P E N D I C E S
Appendix 1. Glossary
Analogues: a substance that is similar to another substance.
Anastomoses: to be linked by anastomosis.
Anastomosis: connection of two structures (in this context, connection between pancreas and small bowel).
Antibodies: a blood protein produced in response to and counteracting a specific antigen.
Covariate: variable that is possibly predictive of the outcome under study.
Enteral: intestinal.
Epithelial surface: a surface lined by epithelium.
Epithelium: membranous tissue composed of one or more layers of cells. It forms the covering of most internal and external surfaces
of the body and its organs.
Fistula: an abnormal duct or passage connecting a cavity or hollow organ to the body surface or to another hollow organ.
Heterogeneity: differences in results between studies.
Immunochemical: using antibodies (blood proteins produced in response to and counteracting a specific antigen such as bacteria, virus,
or part of tissue) to find the presence of a substance or to measure the amount of a substance.
In situ: in its original position in the body.
Intra-abdominal: situated within the abdomen.
Isoforms: two or more functionally similar proteins that have a similar but not identical composition.
Magnetic resonance cholangio pancreatography: medical imaging technique that uses magnetic resonance imaging (use of magnetic
field to differentiate between different structures) to visualize the biliary and pancreatic ducts in a non-invasive manner.
Monoclonal: forming a clone from a single individual or cell.
Morbidity: illness (in this context, it means complications).
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Mortality: death.
Pancreatectomy: removal of part of pancreas.
Pancreatic ductal system: tubular system that transports the pancreatic juice secreted by the pancreatic cells to the small intestine.
Pancreatic leak: leakage of pancreatic section or intestinal contents into the abdomen, resulting in localised or blood stream infection.
Pancreaticoduodenectomy: removal of part of pancreas and duodenum (first part of the small intestine).
Pancreaticogastrostomy: connecting the pancreatic duct to the stomach.
Pancreaticojejunostomy: connecting the pancreatic duct to the jejunum (second part of the small intestine).
Pancreato-enteric: connecting the pancreatic duct to the intestine.
Parenchymal: functional parts of an organ.
Parenteral: administered into the body in a manner other than through the gut (in this context by a drip).
Paucity: presence of something in a small amount.
Percutaneous: through the skin.
Peripancreatic: adjacent to the pancreas.
Peritonitis: inflammation of the lining of the abdomen, usually due to chemical irritation or infection.
Resection: the surgical removal of a body part.
Sepsis: life-threatening illness due to blood infection with bacteria, fungus, or virus.
Thresholds: limits.
Appendix 2. MEDLINE search strategy
1. (ampulla vateri or ampullovateric or papilla vateri or vater papilla or vater ampulla or periampull* or peri-ampull* or choledoch* or
alcholedoch* or bile duct* or biliary or cholangio* or gall duct or duoden* or small bowel or small intestin* or enter* or pancrea*).ti,ab.
2. exp “Ampulla of Vater”/ or exp Pancreas/ or exp Bile Ducts/ or exp Duodenum/
3. 1 or 2
4. (surger* or surgical* or operat* or resection*).ti,ab.
5. 3 and 4
6. (pancreatect* or pancreaticojejunost* or pancreaticogastros* or pancreaticoduodenect* or duodenopancreatectom*).ti,ab.
7. exp Pancreatectomy/
8. exp Pancreaticojejunostomy/
9. exp Pancreaticoduodenectomy/
10. 5 or 6 or 7 or 8 or 9
11. (amylase or amylases).ti,ab.
12. exp Amylases/
13. 11 or 12
14. (drain* or leak or fistula).ti,ab.
15. exp Drainage/
16. exp Anastomotic Leak/
17. exp Pancreatic Fistula/
18. 14 or 15 or 16 or 17
19. 10 and 13 and 18
Appendix 3. Embase search strategy
1. (ampulla vateri or ampullovateric or papilla vateri or vater papilla or vater ampulla or periampull* or peri-ampull* or choledoch* or
alcholedoch* or bile duct* or biliary or cholangio* or gall duct or duoden* or small bowel or small intestin* or enter* or pancrea*).ti,ab.
2. exp duodenum cancer/ or Vater papilla tumor/ or exp pancreas cancer/ or exp bile duct tumor/
3. 1 or 2
4. (surger* or surgical* or operat* or resection*).ti,ab.
5. exp Surgery/
6. 4 or 5
7. 3 and 6
8. (pancreatect* or pancreaticojejunost* or pancreaticogastros* or pancreaticoduodenect* or duodenopancreatectom*).ti,ab.
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9. exp pancreas surgery/
10. 7 or 8 or 9
11. amylase.ti,ab.
12. exp amylase/
13. 11 or 12
14. (drain* or leak or fistula).ti,ab.
15. exp drain/
16. exp anastomosis leakage/
17. exp pancreas fistula/
18. 14 or 15 or 16 or 17
19. 10 and 13 and 18
Appendix 4. Science Citation Index search strategy
#1 TS=(ampulla vateri or ampullovateric or papilla vateri or vater papilla or vater ampulla or periampull* or peri-ampull* or choledoch*
or alcholedoch* or bile duct* or biliary or cholangio* or gall duct or duoden* or small bowel or small intestin* or enter* or pancrea*)
#2 TS=(operat* OR surger* OR surgical* OR resection*)
#3 #1 AND #2
#4 TS=(pancreatect* OR pancreaticojejunost* OR pancreaticogastros* OR pancreaticoduodenect* OR duodenopancreatectom*)
#5 #3 OR #4
#6 TS=(amylase)
#7 TS=(drain* or leak or fistula)
#8 #5 AND #6 AND #7
Appendix 5. National Institute for Health Research - Health Technology Assessment search strategy
pancrea* AND amylase
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. Because of the lack of any studies using the reference standards described in the protocol, we accepted ISGPF grades B and C
POPF as reference standards. People with grade C POPF require surgery while those with grade B POPF usually do not undergo
surgery and may require minimally invasive drainage (Bassi 2005). These people with grade B POPF do not have sepsis but have
localised intra-abdominal infection. Although the intra-abdominal infections are usually because of pancreatic leaks in people
undergoing pancreatic resection (these leaks are usually at least partially ’contained’ (i.e. the effects limited) by the body’s defence
mechanism), one cannot be sure that the intra-abdominal infection was because of pancreatic leak. So, the reference standards used in
this review might misclassify the target condition of pancreatic leak.
2. We searched MEDLINE through OvidSP platform rather than the PubMed platform. This was to avoid limitations of the
search strategy in truncating the words searched to 600 variations when truncation terms were used.
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